Back

Angiotensin receptor-neprilysin inhibitor preserved cardiac function via improving angiogenetic ability in mice model of atherosclerosis

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Basic science heart failure Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Yasunori Suematsu

Fukuoka University School of Medicine, Fukuoka (Japan)

9 More presentations in this session

Presentation thumbnail
P300-mediated inactivation of p53 protects against doxorubicin-induced cardiotoxicity
Mr M. Adam (Toronto, CA)
Abstract
Presentation thumbnail
Epigenetic modifications and gene expressions in Mybpc3 knockout mice
Doctor M. Hossain (Stockholm, SE)
Abstract Slides
Presentation thumbnail
The BNP reporter mouse by knock-in technology is useful for the analysis of mechanism in reactivation of BNP in adult heart
Professor R. Okamoto (Tsu, JP)
Abstract
Presentation thumbnail
Cardiac abnormalities after induction of endoplasmic reticulum stress are associated with mitochondrial dysfunction and connexin43 expression
Professor G. Tse (Hong Kong, CN)
Abstract
Presentation thumbnail
Protective effect of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in spontaneous hypertensive rats
Doctor T. Lin (Taipei, TW)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Basic science heart failure

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources